Kazia Therapeutics Ltd SEC filings KZIA
Kazia Therapeutics Ltd has 1,000 filings in SEC EDGAR's recent list, going back to May 1, 2007. Its latest annual report, Form 20-F, was filed on Nov 7, 2025 for the period ended Jun 30, 2025. The most recent current report (Form 6-K) was filed on Sep 22, 2026. The company's fiscal year ends on June 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| NT 20-F | Filing | Nov 2, 2026 | Jun 30, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Oct 2, 2026 | — |
| 424B3 | Prospectus | Sep 22, 2026 | — |
| 424B3 | Prospectus | Sep 22, 2026 | — |
| 424B3 | Prospectus | Sep 22, 2026 | — |
| 424B3 | Prospectus | Sep 22, 2026 | — |
| 6-K | Current report (foreign issuer) | Sep 22, 2026 | Sep 22, 2026 |
| 424B3 | Prospectus | Sep 18, 2026 | — |
| 424B3 | Prospectus | Sep 18, 2026 | — |
| 424B3 | Prospectus | Sep 18, 2026 | — |
| 424B3 | Prospectus | Sep 18, 2026 | — |
| 6-K | Current report (foreign issuer) | Sep 18, 2026 | Sep 18, 2026 |
| 424B3 | Prospectus | Sep 1, 2026 | — |
| 424B3 | Prospectus | Sep 1, 2026 | — |
| 424B3 | Prospectus | Sep 1, 2026 | — |
| 424B3 | Prospectus | Sep 1, 2026 | — |
| 6-K | Current report (foreign issuer) | Sep 1, 2026 | Sep 1, 2026 |
| 424B3 | Prospectus | Aug 31, 2026 | — |
| 424B3 | Prospectus | Aug 31, 2026 | — |
| 424B3 | Prospectus | Aug 31, 2026 | — |
| 424B3 | Prospectus | Aug 31, 2026 | — |
| 6-K | Current report (foreign issuer) | Aug 31, 2026 | Aug 31, 2026 |
| 6-K | Current report (foreign issuer) | Aug 31, 2026 | Aug 31, 2026 |
| 424B5 | Prospectus supplement | Aug 31, 2026 | — |
| 6-K | Current report (foreign issuer) | Aug 28, 2026 | Aug 28, 2026 |
| 424B5 | Prospectus supplement | Aug 28, 2026 | — |
| 424B5 | Prospectus supplement | Aug 27, 2026 | — |
| 424B3 | Prospectus | Aug 27, 2026 | — |
| 424B3 | Prospectus | Aug 27, 2026 | — |
| 424B3 | Prospectus | Aug 27, 2026 | — |
| 424B3 | Prospectus | Aug 27, 2026 | — |
| 6-K | Current report (foreign issuer) | Aug 27, 2026 | Aug 27, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 19, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| 424B3 | Prospectus | Jul 28, 2026 | — |
| 424B3 | Prospectus | Jul 28, 2026 | — |
| 424B3 | Prospectus | Jul 28, 2026 | — |
| 424B3 | Prospectus | Jul 28, 2026 | — |
| 6-K | Current report (foreign issuer) | Jul 28, 2026 | Jul 28, 2026 |
| 4 | Insider transaction | Jul 8, 2026 | Jan 8, 2026 |
| 4 | Insider transaction | Jul 8, 2026 | Jan 8, 2026 |
| 4 | Insider transaction | Jul 8, 2026 | Jan 8, 2026 |
| 4 | Insider transaction | Jul 8, 2026 | Jan 8, 2026 |
| 4 | Insider transaction | Jul 8, 2026 | Jan 8, 2026 |
| 4 | Insider transaction | Jul 8, 2026 | Jan 8, 2026 |
| 4 | Insider transaction | Jun 23, 2026 | Jun 19, 2026 |
| 4 | Insider transaction | Jun 23, 2026 | Jun 19, 2026 |
| 3 | Initial insider ownership | Jun 15, 2026 | Jun 1, 2026 |
| 3 | Initial insider ownership | Jun 3, 2026 | Mar 18, 2026 |
| 424B3 | Prospectus | Jun 2, 2026 | — |
| 424B3 | Prospectus | Jun 2, 2026 | — |
| 424B3 | Prospectus | Jun 2, 2026 | — |
| 424B3 | Prospectus | Jun 2, 2026 | — |
| 6-K | Current report (foreign issuer) | Jun 2, 2026 | Jun 2, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 27, 2026 | — |
| 424B3 | Prospectus | May 26, 2026 | — |
| 424B3 | Prospectus | May 26, 2026 | — |
| 424B3 | Prospectus | May 26, 2026 | — |
| 424B3 | Prospectus | May 26, 2026 | — |
| 6-K | Current report (foreign issuer) | May 26, 2026 | May 26, 2026 |
| 3 | Initial insider ownership | May 19, 2026 | Apr 13, 2026 |
| 6-K | Current report (foreign issuer) | Apr 27, 2026 | Apr 27, 2026 |
| 424B3 | Prospectus | Apr 15, 2026 | — |
| 424B3 | Prospectus | Apr 15, 2026 | — |
| 424B3 | Prospectus | Apr 15, 2026 | — |
| 424B3 | Prospectus | Apr 15, 2026 | — |
| 6-K | Current report (foreign issuer) | Apr 15, 2026 | Apr 15, 2026 |
| 424B3 | Prospectus | Apr 13, 2026 | — |
| 424B3 | Prospectus | Apr 13, 2026 | — |
| 424B3 | Prospectus | Apr 13, 2026 | — |
| 424B3 | Prospectus | Apr 13, 2026 | — |
| 6-K | Current report (foreign issuer) | Apr 13, 2026 | Apr 13, 2026 |
| 3/A | Filing | Apr 9, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Apr 1, 2026 | Mar 18, 2026 |
| 424B3 | Prospectus | Apr 1, 2026 | — |
| 424B3 | Prospectus | Apr 1, 2026 | — |
| 424B3 | Prospectus | Apr 1, 2026 | — |
| 424B3 | Prospectus | Apr 1, 2026 | — |
| 6-K | Current report (foreign issuer) | Mar 31, 2026 | Mar 31, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Mar 31, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Mar 30, 2026 | — |
| 6-K | Current report (foreign issuer) | Mar 30, 2026 | Dec 31, 2025 |
| EFFECT | Filing | Mar 27, 2026 | — |
| CORRESP | Letter to the SEC | Mar 26, 2026 | — |
| UPLOAD | Letter from the SEC | Mar 25, 2026 | — |
| 424B3 | Prospectus | Mar 19, 2026 | — |
| 424B3 | Prospectus | Mar 19, 2026 | — |
| 424B3 | Prospectus | Mar 19, 2026 | — |
| 424B3 | Prospectus | Mar 19, 2026 | — |
| 6-K | Current report (foreign issuer) | Mar 19, 2026 | Dec 31, 2025 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| F-3 | Shelf registration (foreign issuer) | Mar 18, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 20, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 12, 2026 | — |
| 424B3 | Prospectus | Jan 27, 2026 | — |
| 424B3 | Prospectus | Jan 27, 2026 | — |
| 424B3 | Prospectus | Jan 27, 2026 | — |
| 424B3 | Prospectus | Jan 27, 2026 | — |
| 6-K | Current report (foreign issuer) | Jan 27, 2026 | Jan 27, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 23, 2026 | — |
| EFFECT | Filing | Dec 23, 2025 | — |
| EFFECT | Filing | Dec 23, 2025 | — |
| 424B3 | Prospectus | Dec 23, 2025 | — |
| 424B3 | Prospectus | Dec 23, 2025 | — |
| 424B3 | Prospectus | Dec 23, 2025 | — |
| 424B3 | Prospectus | Dec 23, 2025 | — |
| EFFECT | Filing | Dec 22, 2025 | — |
| EFFECT | Filing | Dec 22, 2025 | — |
| CORRESP | Letter to the SEC | Dec 22, 2025 | — |
| CORRESP | Letter to the SEC | Dec 22, 2025 | — |
| POS AM | Filing | Dec 19, 2025 | — |
| POS AM | Filing | Dec 19, 2025 | — |
| F-1/A | Filing | Dec 19, 2025 | — |
| F-1 | Registration statement (foreign issuer) | Dec 19, 2025 | — |
| 6-K | Current report (foreign issuer) | Dec 19, 2025 | Dec 19, 2025 |
| D | Filing | Dec 18, 2025 | — |
| 6-K | Current report (foreign issuer) | Dec 10, 2025 | Dec 10, 2025 |
| 6-K | Current report (foreign issuer) | Dec 5, 2025 | Dec 5, 2025 |
| 6-K | Current report (foreign issuer) | Dec 2, 2025 | Dec 2, 2025 |
| 424B3 | Prospectus | Nov 18, 2025 | — |
| 424B3 | Prospectus | Nov 18, 2025 | — |
| 424B3 | Prospectus | Nov 18, 2025 | — |
| 6-K | Current report (foreign issuer) | Nov 18, 2025 | Nov 18, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| 20-F | Annual report (foreign issuer) | Nov 7, 2025 | Jun 30, 2025 |
| NT 20-F | Filing | Oct 31, 2025 | Jun 30, 2025 |
| 424B3 | Prospectus | Oct 7, 2025 | — |
| 424B3 | Prospectus | Oct 7, 2025 | — |
| 424B3 | Prospectus | Oct 7, 2025 | — |
| 6-K | Current report (foreign issuer) | Oct 7, 2025 | Oct 7, 2025 |
| 424B3 | Prospectus | Oct 2, 2025 | — |
| 424B3 | Prospectus | Oct 2, 2025 | — |
| 424B3 | Prospectus | Oct 2, 2025 | — |
| 6-K | Current report (foreign issuer) | Oct 2, 2025 | Oct 2, 2025 |
| F-1 | Registration statement (foreign issuer) | Sep 30, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Sep 12, 2025 | — |
| 424B3 | Prospectus | Sep 11, 2025 | — |
| 424B3 | Prospectus | Sep 11, 2025 | — |
| 424B3 | Prospectus | Sep 11, 2025 | — |
| 6-K | Current report (foreign issuer) | Sep 11, 2025 | Sep 11, 2025 |
| D | Filing | Aug 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 5, 2025 | — |
| 424B3 | Prospectus | Aug 1, 2025 | — |
| 424B3 | Prospectus | Aug 1, 2025 | — |
| 424B3 | Prospectus | Aug 1, 2025 | — |
| 6-K | Current report (foreign issuer) | Aug 1, 2025 | Aug 1, 2025 |
| 424B3 | Prospectus | Jul 25, 2025 | — |
| 424B3 | Prospectus | Jul 25, 2025 | — |
| 424B3 | Prospectus | Jul 25, 2025 | — |
| 6-K | Current report (foreign issuer) | Jul 25, 2025 | Jul 25, 2025 |
| 424B5 | Prospectus supplement | Jul 25, 2025 | — |
| 424B3 | Prospectus | Jul 9, 2025 | — |
| 424B3 | Prospectus | Jul 9, 2025 | — |
| 424B3 | Prospectus | Jul 9, 2025 | — |
| 6-K | Current report (foreign issuer) | Jul 9, 2025 | Jul 9, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jun 13, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jun 12, 2025 | — |
| 424B3 | Prospectus | Jun 11, 2025 | — |
| 424B3 | Prospectus | Jun 11, 2025 | — |
| 424B3 | Prospectus | Jun 11, 2025 | — |
| 6-K | Current report (foreign issuer) | Jun 11, 2025 | Jun 11, 2025 |
| 424B3 | Prospectus | Jun 10, 2025 | — |
| 424B3 | Prospectus | Jun 10, 2025 | — |
| 424B3 | Prospectus | Jun 10, 2025 | — |
| 6-K | Current report (foreign issuer) | Jun 10, 2025 | Dec 31, 2024 |
| 424B3 | Prospectus | Jun 5, 2025 | — |
| 424B3 | Prospectus | Jun 5, 2025 | — |
| 424B3 | Prospectus | Jun 5, 2025 | — |
| 6-K | Current report (foreign issuer) | Jun 5, 2025 | Jun 5, 2025 |
| 424B3 | Prospectus | May 28, 2025 | — |
| 424B3 | Prospectus | May 28, 2025 | — |
| 424B3 | Prospectus | May 28, 2025 | — |
| 6-K | Current report (foreign issuer) | May 28, 2025 | May 28, 2025 |
| 424B3 | Prospectus | May 15, 2025 | — |
| 424B3 | Prospectus | May 15, 2025 | — |
| 424B3 | Prospectus | May 15, 2025 | — |
| 6-K | Current report (foreign issuer) | May 15, 2025 | May 15, 2025 |
| 424B3 | Prospectus | Apr 15, 2025 | — |
| 424B3 | Prospectus | Apr 15, 2025 | — |
| 424B3 | Prospectus | Apr 15, 2025 | — |
| 6-K | Current report (foreign issuer) | Apr 15, 2025 | Apr 15, 2025 |
| 424B3 | Prospectus | Mar 31, 2025 | — |
| 424B3 | Prospectus | Mar 31, 2025 | — |
| 424B3 | Prospectus | Mar 31, 2025 | — |
| 6-K | Current report (foreign issuer) | Mar 31, 2025 | Mar 31, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Mar 19, 2025 | — |
| 6-K | Current report (foreign issuer) | Mar 13, 2025 | Mar 12, 2025 |
| 424B3 | Prospectus | Feb 21, 2025 | — |
| 424B3 | Prospectus | Feb 20, 2025 | — |
| 424B3 | Prospectus | Feb 20, 2025 | — |
| 6-K | Current report (foreign issuer) | Feb 20, 2025 | Feb 20, 2025 |
| EFFECT | Filing | Feb 5, 2025 | — |
| 424B3 | Prospectus | Feb 5, 2025 | — |
| CORRESP | Letter to the SEC | Feb 3, 2025 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- KZIA (Nasdaq)
- Fiscal year ends
- June 30
- Incorporated in
- Australia
- Headquarters
- Sydney Nsw
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1075880
- Former names
- NOVOGEN LTD (until Nov 17, 2017)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.